Shozo Yamamoto
#130,350
Most Influential Person Now
Shozo Yamamoto's AcademicInfluence.com Rankings
Shozo Yamamotobiology Degrees
Biology
#8561
World Rank
#11658
Historical Rank
Molecular Biology
#1097
World Rank
#1122
Historical Rank
Biochemistry
#1246
World Rank
#1365
Historical Rank
Download Badge
Chemistry Biology
Shozo Yamamoto's Degrees
- PhD Biochemistry University of Tokyo
- Masters Chemistry University of Tokyo
Why Is Shozo Yamamoto Influential?
(Suggest an Edit or Addition)Shozo Yamamoto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. (1976) (591)
- Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions (1993) (369)
- Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. (1987) (336)
- Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand (1998) (326)
- Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. (1979) (321)
- The fatty acid amide hydrolase (FAAH). (2000) (311)
- Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. (2009) (302)
- Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. (1992) (232)
- Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. (1999) (231)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. (1983) (219)
- Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase. (1983) (196)
- Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. (1999) (191)
- Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. (1997) (190)
- Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. (1977) (188)
- Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. Activation by adenosine 5'-triphosphate. (1983) (182)
- Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. (1995) (169)
- Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. (1998) (156)
- Purification of arachidonate 5-lipoxygenase from porcine leukocytes and its reactivity with hydroperoxyeicosatetraenoic acids. (1986) (152)
- Contribution of ATP-sensitive potassium channels to hypoxic hyperpolarization in rat hippocampal CA1 neurons in vitro. (1997) (152)
- Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. (1990) (143)
- Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. (1989) (143)
- Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor. (1986) (141)
- Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. (1996) (140)
- Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. (1987) (139)
- The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. (1989) (136)
- Baicalin, an inhibitor of HIV-1 production in vitro. (1998) (136)
- Arachidonate 12-lipoxygenase purified from porcine leukocytes by immunoaffinity chromatography and its reactivity with hydroperoxyeicosatetraenoic acids. (1986) (135)
- Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. (1990) (133)
- A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. (1993) (131)
- Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. (1990) (131)
- Fluid shear stress increases the expression of thrombomodulin by cultured human endothelial cells. (1994) (130)
- Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. (1996) (130)
- Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. (1997) (128)
- Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. (2001) (126)
- Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. (1994) (124)
- Prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. Inactivation and activation by heme and other metalloporphyrins. (1978) (123)
- Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. (1997) (117)
- The fatty acid amide hydrolase (FAAH). (2002) (116)
- Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. (1997) (112)
- The potent anti-tumor-promoting agent isoliquiritigenin. (1991) (111)
- Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. (1977) (110)
- Purification and properties of prostaglandin D synthetase from rat brain. (1979) (104)
- Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain. (2000) (103)
- Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. (1997) (99)
- An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors (1999) (99)
- Gene expression of glucose transporter (GLUT) 1, 3 and 4 in bovine follicle and corpus luteum. (2006) (99)
- A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. (1989) (97)
- Failure of 1-oleoyl-2-acetylglycerol to mimic the cell-differentiating action of 12-O-tetradecanoylphorbol 13-acetate in HL-60 cells. (1985) (96)
- Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. (1998) (90)
- Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. (1997) (90)
- Prostaglandin synthetase system--resolution into oxygenase and isomerase components. (1974) (90)
- Lipoxin synthase activity of human platelet 12-lipoxygenase. (1993) (89)
- Two immunologically and catalytically distinct arachidonate 12-lipoxygenases of bovine platelets and leukocytes. (1988) (89)
- Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. (1993) (86)
- Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression. (1995) (85)
- 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. (1982) (83)
- cDNA cloning and inducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin omega-hydroxylase (cytochrome P-450p-2). (1987) (83)
- Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum. (1982) (81)
- Arachidonate 12-lipoxygenase of platelet-type in human epidermal cells. (1993) (80)
- Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. (1995) (80)
- Factors that reverse the persistent depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. (1997) (80)
- Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography. (2001) (78)
- Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase. (1997) (77)
- Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. (1995) (77)
- Panaxynol, a polyacetylene compound isolated from oriental medicines, inhibits mammalian lipoxygenases. (1994) (74)
- Molecular cloning and expression of endo-beta-N-acetylglucosaminidase D, which acts on the core structure of complex type asparagine-linked oligosaccharides. (2001) (73)
- Catalytic properties of human platelet 12-lipoxygenase as compared with the enzymes of other origins. (1991) (73)
- Mediation by intracellular calcium-dependent signals of hypoxic hyperpolarization in rat hippocampal CA1 neurons in vitro. (1997) (70)
- Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. (2001) (68)
- Further localization of binding sites for thrombin and protein C in human thrombomodulin. (1990) (68)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor. (1982) (67)
- Site-directed mutagenesis studies on the iron-binding domain and the determinant for the substrate oxygenation site of porcine leukocyte arachidonate 12-lipoxygenase. (1994) (66)
- The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis). (1997) (65)
- Membrane dysfunction induced by in vitro ischemia in rat hippocampal CA1 pyramidal neurons. (1999) (64)
- Studies on the induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathways. (1994) (62)
- Fully enzymatic method for determining 1,5-anhydro-D-glucitol in serum. (1994) (61)
- Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles. (1978) (60)
- Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. (1994) (58)
- New induction of leukotriene A(4) hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes. (2000) (58)
- Molecular cloning and expression of human arachidonate 12-lipoxygenase. (1990) (57)
- Toluene induces rapid and reversible rise of hippocampal glutamate and taurine neurotransmitter levels in mice. (2007) (56)
- Modulation of insulin secretion by lipoxygenase products of arachidonic acid. Relation to lipoxygenase activity of pancreatic islets. (1983) (56)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway. (1982) (55)
- Induction of arachidonate 12-lipoxygenase mRNA by epidermal growth factor in A431 cells. (1993) (55)
- Identification of a novel arachidonate 12-lipoxygenase in bovine tracheal epithelial cells distinct from leukocyte and platelet forms of the enzyme. (1990) (54)
- Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction. (1991) (54)
- Evidence that a leukocyte type of 12-lipoxygenase is expressed and regulated by angiotensin II in human adrenal glomerulosa cells. (1994) (54)
- Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm. (1995) (54)
- Anandamide amidohydrolase (fatty acid amide hydrolase). (2000) (54)
- Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. (1997) (53)
- cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3-E1). (1991) (53)
- Isolation of cytochrome P-450 highly active in prostaglandin omega-hydroxylation from lung microsomes of rabbits treated with progesterone. (1984) (53)
- Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. (1993) (52)
- Gene structure of human thrombomodulin, a cofactor for thrombin-catalyzed activation of protein C. (1988) (51)
- Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. (1993) (50)
- Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. (1994) (50)
- Sodium influx rate and ouabain-sensitive rubidium uptake in isolated guinea pig atria. (1979) (50)
- Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts. (1983) (49)
- Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis(1). (1999) (49)
- The linoleic acid derivative FR236924 facilitates hippocampal synaptic transmission by enhancing activity of presynaptic α7 acetylcholine receptors on the glutamatergic terminals (2005) (48)
- A prenylflavone, artonin E, as arachidonate 5-lipoxygenase inhibitor. (1991) (48)
- Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation. (1989) (47)
- Partial purification and characterization of arachidonate 12-lipoxygenase from rat lung. (1983) (47)
- A heterologous enzyme immunoassay of prostaglandin E2 using a stable enzyme-labeled hapten mimic. (1988) (47)
- Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. (1995) (46)
- Arachidonate 12-lipoxygenase of rat pineal glands: catalytic properties and primary structure deduced from its cDNA. (1994) (46)
- Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme. (1999) (45)
- Isolation of an activator for prostaglandin hydroperoxidase from bovine vesicular gland cytosol and its identification as uric acid. (1979) (44)
- Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase. (2000) (44)
- Lipoxin synthesis by arachidonate 12-lipoxygenase purified from porcine leukocytes. (1987) (44)
- Inhibition of leukotriene synthesis by azelastine. (1996) (44)
- Is ouabain-sensitive rubidium or potassium uptake a measure of sodium pump activity in isolated cardiac muscle? (1981) (43)
- Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP. (1988) (43)
- Structure and chromosomal localization of human arachidonate 12-lipoxygenase gene. (1992) (43)
- Arachidonate 5-lipoxygenase and its new inhibitors. (1984) (42)
- Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. (1997) (42)
- Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation. (1983) (42)
- Staurosporine, a potent protein kinase C inhibitor, fails to inhibit 12-O-tetradecanoylphorbol-13-acetate-caused ornithine decarboxylase induction in isolated mouse epidermal cells. (1987) (42)
- Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca(2+)-mediated binding to protein C. (1991) (42)
- Studies on porcine arachidonate 12-lipoxygenase using its monoclonal antibodies. (1986) (41)
- Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis. (2013) (41)
- Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate. (1999) (41)
- Fatty acid cyclooxygenase activity stimulated by transforming growth factor-beta in mouse osteoblastic cells (MC3T3-E1). (1989) (40)
- Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase. (2000) (40)
- Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). (1992) (40)
- Induction of cyclooxygenase-1 in a human megakaryoblastic cell line (CMK) differentiated by phorbol ester. (1997) (39)
- Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage. (1997) (39)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects. (1986) (39)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. (1985) (38)
- Effects of inhibitors of arachidonic acid metabolism on calcium uptake and catecholamine release in cultured adrenal chromaffin cells. (1984) (38)
- Expression of 11beta-hydroxysteroid dehydrogenases in bovine follicle and corpus luteum. (2003) (38)
- Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase. (1983) (38)
- Prevention of glucose-induced insulin secretion by lipoxygenase inhibitor. (1982) (37)
- A flavonoid inhibitor of 5-lipoxygenase inhibits leukotriene production following ischemia in gerbil brain. (1989) (37)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine. (1986) (36)
- Suicide inactivation of porcine leukocyte 12-lipoxygenase associated with its incorporation of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid derivative. (1996) (36)
- Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides. (1989) (36)
- beta-Microseminoprotein/prostatic secretory protein is a member of immunoglobulin binding factor family. (1998) (35)
- Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways. (1999) (35)
- IL-10 gene transfer upregulates arcuate POMC and ameliorates hyperphagia, obesity and diabetes by substituting for leptin (2016) (35)
- Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate. (1984) (35)
- Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells. (1999) (35)
- Release of peptide leukotrienes from rat Kupffer cells. (1988) (34)
- Inhibition of dibutyryl cyclic AMP-induced insulin release by alpha-2 adrenergic stimulation. (1983) (34)
- Propofol-induced depression of cultured rat ventricular myocytes is related to the M2-acetylcholine receptor-NO-cGMP signaling pathway. (1999) (34)
- Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomes. (1994) (33)
- Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase. (1993) (33)
- Localization of arachidonate 12-lipoxygenase in parenchymal cells of porcine anterior pituitary. (1990) (33)
- Functional shift from muscarinic to nicotinic cholinergic receptors involved in inositol trisphosphate and cyclic GMP accumulation during the primary culture of adrenal chromaffin cells. (1988) (32)
- ENZYMATIC HISTAMINE DEGRADATION BY HUMAN SKIN (1977) (32)
- Cytochrome P-450 and NADPH-Cytochrome P-450 Reductase Are Degraded in the Autolysosomes in Rat Liver (2003) (32)
- Syntheses of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase. (1986) (31)
- Studies on monooxygenases. I. General properties of crystalline L-lysine monooxygenase. (1969) (31)
- Single amino acid substitutions within the ion permeation pathway alter single-channel conductance of the human L-type cardiac Ca2+ channel. (1994) (31)
- A novel species of cytochrome P-450 (P-450ib) specific for the small intestine of rabbits. cDNA cloning and its expression in COS cells. (1991) (30)
- Induction of ornithine decarboxylase activity by 1-oleoyl-2-acetyl-glycerol in isolated mouse epidermal cells. (1985) (30)
- Effects of vanadate on Na+,K+-ATPase and on the force of contraction in guinea-pig hearts. (1979) (30)
- Tumor promotor 12-O-tetradecanoylphorbol-13-acetate-induced insulin secretion: inhibition by phospholipase A2-and lipoxygenase-inhibitors. (1982) (30)
- Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor. (1994) (30)
- The enzymatic conversion of arachidonic acid into 8,11,12-trihydroxyeicosatrienoic acid. Resolution of rat lung enzyme into two active fractions. (1982) (29)
- Calcium uptake-dependent and -independent mechanisms of inositol trisphosphate formation in adrenal chromaffin cells: comparative studies with high K+, carbamylcholine and angiotensin II. (1989) (29)
- Stable expression and coupling of cardiac L-type Ca2+ channels with beta 1-adrenoceptors. (1995) (29)
- Interrelation between protein kinase C and nitric oxide in the development of vasospasm after subarachnoid hemorrhage. (1996) (29)
- Optimization for beta-mannanase production of a psychrophilic bacterium, Flavobacterium sp. (1998) (29)
- Insulinotropic effects of exogenous phospholipase A2 and C in isolated pancreatic islets. (1982) (29)
- Butyric acid and tributyrin induce apoptosis in human hepatic tumour cells (1999) (29)
- The 6R-oxygenase activity of arachidonate 5-lipoxygenase purified from porcine leukocytes. (1988) (28)
- Induction of cyclooxygenase type-2 (COX-2) in rat endometrium at the peak of serum estradiol during the estrus cycle. (1995) (28)
- dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells (2005) (28)
- Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. (1994) (28)
- Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. (2000) (28)
- SM-20550, a new Na+/H+ exchange inhibitor and its cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload. (2000) (28)
- Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. (1990) (28)
- Effect of polyamines on phosphorylation of non-histone chromatin proteins from hog liver. (1975) (27)
- 6-Mercaptopurine (6-MP) induces cell cycle arrest and apoptosis of neural progenitor cells in the developing fetal rat brain. (2009) (27)
- Inhibition of leukotriene synthesis by honokiol in rat basophilic leukemia cells. (1996) (27)
- Immunocytochemical localization of platelet-type arachidonate 12-lipoxygenase in mouse blood cells. (1995) (27)
- Regional distribution of prostaglandin endoperoxide synthase studied by enzyme-linked immunoassay using monoclonal antibodies. (1986) (26)
- Studies on the tryptophan-dependent light emission by prostaglandin hydroperoxidase reaction. (1980) (26)
- Dissociation-association of lactate dehydrogenase isozymes: influences on the formation of tetramers versus dimers of M4-LDH and H4-LDH. (1988) (26)
- Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes. (2000) (25)
- Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol. (2001) (25)
- Molecular structure and function of the porcine arachidonate 12-lipoxygenase gene. (1992) (25)
- Opioid systems in the lateral hypothalamus regulate feeding behavior through orexin and GABA neurons (2016) (25)
- A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. (1998) (25)
- Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines. (1997) (25)
- The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals (2001) (24)
- Mechanism of alpha-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells. (2000) (24)
- Inhibition of teleocidin-caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase-inhibitors. (1985) (24)
- Structures of the sugar chains of interferon-gamma produced by human myelomonocyte cell line HBL-38. (1989) (24)
- Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. (2000) (24)
- Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs. (2001) (24)
- Inhibition by dexamethasone of the lipopolysaccharide-induced increase in IL-6 mRNA abundance and IL-6 production in human polymorphonuclear leukocytes. (1996) (23)
- Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats. (1998) (23)
- Effect of SMP-300, a new Na+/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats. (2000) (23)
- Arachidonate 5-lipoxygenase of porcine leukocytes studied by enzyme immunoassay using monoclonal antibodies. (1987) (23)
- Preparation and growth of yeast protoplasts. (1975) (23)
- Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers. (1996) (23)
- Some properties of lipoxygenase activities in cytosol and microsomal fractions of mouse epidermal homogenate. (1986) (23)
- Enzyme immunoassay of thromboxane B2. (1983) (22)
- Differential effects of various skin tumor-promoting agents on prostaglandin E2 release from primary cultures of mouse epidermal cells. (1990) (22)
- Serine 331 is the major site of receptor phosphorylation induced by agents that activate protein kinase G in HEK 293 cells overexpressing thromboxane receptor alpha. (2001) (22)
- Urinary thrombomodulin, its isolation and characterization. (1993) (22)
- Studies on the sugar chains of interferon-gamma from human peripheral-blood lymphocytes. (1989) (22)
- Reactions of prostaglandin endoperoxides with prostaglandin I synthetase solubilized from rabbit aorta microsomes. (1979) (22)
- Enhanced expression of thrombomodulin by intracellular cyclic AMP-increasing agents in two human megakaryoblastic leukemia cell lines. (1990) (22)
- Amino acid substitutions in the rat Na+, K(+)‐ATPase alpha 2‐subunit alter the cation regulation of pump current expressed in HeLa cells. (1996) (22)
- Phenylalanine 138 in the second intracellular loop of human thromboxane receptor is critical for receptor-G-protein coupling. (1999) (22)
- Immunohistochemical study of arachidonate 12-lipoxygenase in porcine tissues. (1989) (22)
- Effect of vitamin E on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated rat macrophages. (1996) (21)
- Purification and characterization of cytochrome P-450 specific for prostaglandin and fatty acid hydroxylase activities from the microsomes of rabbit small intestinal mucosa. (1984) (21)
- Changes in cell volume induced by activation of the cyclic amp-dependent chloride channel in guinea-pig cardiac myocytes. (2001) (21)
- Formation of 8,11,12-trihydroxyeicosatrienoic acid by a rat lung high-speed supernatant fraction. (1981) (21)
- Purification and cDNA cloning of human liver CYP4A fatty acid omega-hydroxylase. (1994) (21)
- Membrane dysfunction induced by in vitro ischemia in immature rat hippocampal CA1 neurons. (1999) (21)
- Carbohydrate structures of the glycoprotein allergen Cry j I from Japanese cedar (Cryptomeria japonica) pollen. (1995) (21)
- Expression of porcine leukocyte 12-lipoxygenase in a baculovirus/insect cell system and its characterization. (1994) (20)
- Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP. (1991) (20)
- Medical and biochemical application of infrared absorption spectra. I. Studies on gall stone by infrared spectra and x-ray crystallography. (1958) (20)
- A novel adenosine triphosphatase isolated from RNA polymerase preparations of Escherichia coli. II. Enzymatic properties and molecular structure. (1976) (20)
- Prednisolone-3, 20-bisguanylhydrazone: Na+, K+-ATPase inhibition and positive inotropic action. (1978) (20)
- Analysis of the consensus binding sequence and the DNA-binding domain of ZF5. (1999) (20)
- H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells. (1989) (20)
- Expression, purification, and characterization of porcine leukocyte 12-lipoxygenase produced in the methylotrophic yeast, Pichia pastoris. (1994) (20)
- Identification of a tissue-specific regulatory element within the murine CD14 gene. (1992) (19)
- Induction of cyclooxygenase and suppression of 12-lipoxygenase in human erythroleukemia cells upon phorbol ester-induced differentiation. (1993) (19)
- Epidermal growth factor enhances transcription of human arachidonate 12-lipoxygenase in A431 cells. (1997) (19)
- Syntheses of 5,7,8- and 5,6,7-trioxygenated 3-alkyl-3',4'-dihydroxyflavones and their inhibitory activities against arachidonate 5-lipoxygenase. (1991) (19)
- The presence of phorbol ester responsive and non-responsive forms of the zeta isozyme of protein kinase C in mouse epidermal cells. (1995) (19)
- Cloning and characterization of elastase structural gene from Pseudomonas aeruginosa IFO 3455. (1988) (19)
- Unbalanced production of interleukin-5 and interleukin-2 in children with atopic dermatitis. (1997) (19)
- Mechanisms underlying the enhancement of excitatory synaptic transmission in basolateral amygdala neurons of the kindling rat. (1998) (19)
- Localization of arachidonate 12-lipoxygenase in canine brain tissues. (1991) (19)
- Stereoselective hydrogen abstraction in leukotriene A4 synthesis by purified 5-lipoxygenase of porcine leukocytes. (1986) (19)
- Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice (2013) (18)
- Analysis of non-heme iron in arachidonate 12-lipoxygenase of porcine leukocytes. (1991) (18)
- Inhibition by Brain Natriuretic Peptide of Vasopressin Neurons in the Supraoptic Nucleus and Neurons in the Region of the Anteroventral Third Ventricle in Rat Hypothalamic Slice Preparations (1991) (18)
- Isolation of cortical MTs from tobacco BY-2 cells. (2001) (18)
- Enzymatic activation of immunoglobulin binding factor in female reproductive tract. (1998) (18)
- Theasaponin E1 destroys the salt tolerance of yeasts. (2000) (18)
- Studies on monooxygenases. II. Crystallization and some properties of imidazole acetate monooxygenase. (1969) (17)
- Decreased messenger RNA of arachidonate 12-lipoxygenase in platelets of patients with myeloproliferative disorders. (1993) (17)
- beta-Galactosidase-linked immunoassay of prostaglandin F2 alpha. (1981) (17)
- Hydroxylation of prostaglandin A1 by the microsomes of rabbit intestinal mucosa. (1984) (17)
- Purification and assay of PGH synthase from bovine seminal vesicles. (1982) (17)
- Multiple forms of cytochrome P-450 in rabbit colon microsomes. (1985) (17)
- Reduction of myocardial infarct size by SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits. (2000) (17)
- The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts. (2001) (16)
- A solid-phase enzyme immunoassay of thromboxane B2. (1985) (16)
- Immunohistochemical study on arachidonate 5-lipoxygenase in porcine leukocytes and other tissues. (1991) (16)
- Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan. (1997) (16)
- Studies on arachidonate 5-lipoxygenase of rat basophilic leukemia cells. (1984) (16)
- Separation of two constitutive forms of cytochrome P-450 active in aminopyrine N-demethylation from rabbit intestinal mucosa microsomes. (1985) (15)
- Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. (1993) (15)
- Time-course changes in neural cell apoptosis in the rat fetal brain from dams treated with 6-mercaptopurine (6-MP). (2009) (15)
- Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice. (1989) (15)
- Distribution of natriuretic peptide receptor-C immunoreactivity in the rat brainstem and its relationship to cholinergic and catecholaminergic neurons (2008) (15)
- O-glycosylated species of natural human tumor-necrosis factor-alpha. (1996) (15)
- α1‐Adrenoceptor‐mediated depletion of phosphatidylinositol 4, 5‐bisphosphate inhibits activation of volume‐regulated anion channels in mouse ventricular myocytes (2010) (14)
- Variations in cellular polyamine compositions and contents of Vibrio species during growth in media with various NaCl concentrations. (1986) (14)
- Effect of dexamethasone on leukotriene synthesis in DMSO-stimulated HL-60 cells. (1998) (14)
- Protein kinase C-dependent and -independent actions of a potent protein kinase C inhibitor, staurosporine. (1992) (14)
- Multiple forms of cytochrome P-450 from kidney cortex microsomes of rabbits treated with phenobarbital. (1983) (14)
- Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. (1992) (14)
- Arachidonate 12-lipoxygenase in porcine anterior pituitary cells: its localization and possible function in gonadotrophs. (1996) (14)
- Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models. (1997) (14)
- Urinary excretion of isomers of biliverdin after destruction in vivo of haemoproteins and haemin. (1985) (14)
- Inhibitory effect of TJN-101 ((+)-(6S,7S,R-biar)-5,6,7,8-tetrahydro-1,2,3,12-tetramethoxy -6,7-dimethyl-10,11- methylenedioxy-6-dibenzo[a,c]cyclooctenol) on immunologically induced liver injuries. (1987) (13)
- Saiboku-To, a herbal extract mixture, selectively inhibits 5-lipoxygenase activity in leukotriene synthesis in rat basophilic leukemia-1 cells. (1995) (13)
- The Chinese herbal medicine, shinpi-to, inhibits IgE-mediated leukotriene synthesis in rat basophilic leukemia-2H3 cells. (1997) (13)
- The use of model systems prepared from tobacco BY‐2 cells for studies of the plant cytoskeleton (1996) (13)
- Occurrence of cytochrome P-450 with prostaglandin omega-hydroxylase activity in rabbit placental microsomes. (1986) (13)
- Tissue concentration of Na+, K+-adenosine triphosphatase and the positive inotropic action of ouabain in guinea-pig heart. (1981) (13)
- Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase. (1990) (13)
- Contribution of flavin-containing monooxygenase and cytochrome P450 to imipramine N-oxidation in rat hepatic microsomes. (1999) (13)
- 6-mercaptopurine (6-MP) induces p53-mediated apoptosis of neural progenitor cells in the developing fetal rodent brain. (2009) (13)
- Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus. (1998) (12)
- Cardiovascular-related peptides influence hypothalamic neurons involved in control of body water homeostasis. (1995) (12)
- New spectral species of L-lysine monooxygenase, a flavoprotein. (1971) (12)
- Severity of promotion by sodium salts of succinic acid in rat urinary bladder carcinogenesis correlates with sodium ion concentration under conditions of equal urinary pH. (1993) (12)
- Endothelin-3 directly affects neurons in the anteroventral third ventricle region and supraoptic nucleus of the rat hypothalamus in vitro. (1991) (12)
- Diurnal change of arachidonate 12-lipoxygenase in rat pineal gland. (1997) (12)
- Arachidonate 12-lipoxygenase of porcine leukocyte with activity for 5-hydroxyeicosatetraenoic acid. (1982) (12)
- Purification of PGH-PGD isomerase from rat brain. (1982) (12)
- Inotropic effects and Na+,K+-ATPase inhibition of ouabain in isolated guinea-pig atria and diaphragm. (1981) (12)
- Synthesis and biological activity of novel 2-(alpha-alkoxyimino)benzylpyridine derivatives as K+ channel openers. (1997) (11)
- Positive inotropic action of digoxigenin and sodium pump inhibition: effects of enhanced sodium influx. (1980) (11)
- Effect of intracellular sodium on calcium uptake in isolated guinea-pig diaphragm and atria. (1981) (11)
- Purification and characterization of two forms of fatty acid omega-hydroxylase cytochrome P-450 from rabbit kidney cortex microsomes. (1990) (11)
- Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction. (1992) (11)
- Crystalline enzyme which degrades the cell wall of living yeast. (1972) (11)
- Microdetermination of 11-dehydrothromboxane B2 in human urine by gas chromatography-selected-ion monitoring. (1989) (11)
- Detection of immunoglobulin binding factor by enzyme-linked immunosorbent assay using two monoclonal antibodies. (1994) (11)
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and tumor promotion by N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) in mouse skin. (1986) (11)
- Effects of lipoxygenase and cyclooxygenase inhibitors on the induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissues in vivo. (1986) (11)
- Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon. (1993) (11)
- A selective inhibitor of arachidonate 5-lipoxygenase scavenging peroxide activator. (1997) (10)
- Mechanism of urinary tract crystal formation following biphenyl treatment. (2001) (10)
- Inhibition of anthralin-caused skin tumor promotion and interleukin-1 alpha production by potent immunosuppressant FK506. (1994) (10)
- Studies on monooxygenases. 3. Examinations of metal participation in flavoprotein monooxygenases of pseudomonads. (1969) (10)
- Effect of peroxisomal proliferators on microsomal prostaglandin A omega-hydroxylase. (1986) (10)
- Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver. (1984) (9)
- Effects of hydrocortisone and aminophylline on plasma leukotriene C4 levels in patients during an asthmatic attack. (1990) (9)
- Differential effects of protein kinase C activators on carbamylcholine- and high K+-induced rises in intracellular free calcium concentration in cultured adrenal chromaffin cells. (1986) (9)
- A possible involvement of sulfhydryl groups in the conversion of lysine monooxygenase to an oxidase. (1975) (9)
- Suppressive effect of transforming growth factor-beta on the phosphorylation of endogenous substrates by conventional and novel protein kinase C in primary cultured mouse epidermal cells. (1993) (9)
- Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophylline and dibutyryl cyclic AMP. (1985) (9)
- Mechanistic studies of the dioxygenase and leukotriene synthase activities of the porcine leukocyte 12S-lipoxygenase. (1989) (9)
- Role of nitric oxide production through M2-cholinergic receptors in cultured rat ventricular myocytes. (1998) (9)
- Arachidonate 5-lipoxygenase of porcine pancreas: its localization in acinar cells. (1991) (9)
- Potentiation of prostaglandin E1-stimulated cAMP formation by 12-O-tetradecanoylphorbol-13-acetate in BALB/c mouse 3T3 cells. (1986) (9)
- Phosphorylation and dephosphorylation of human promyelocytic leukemia cell (HL-60) proteins by tumor promoter. (1984) (8)
- Amide-bridged ladder poly(p-phenylene): synthesis by direct arylation and π-stacked assembly (2015) (8)
- Active transport activities of free B-6 vitamers in various yeast strains. (1996) (8)
- Effect of brain-gut peptides upon neurons in centrally regulating sites for drinking. (1989) (8)
- Enzyme immunoassay of human plasma 11-dehydrothromboxane B2. (1991) (8)
- Stimulation of 6-keto-prostaglandin F1 alpha release from isolated pancreatic islets by an insulinotropic concentration of glucose. (1983) (8)
- Potassium depletion modulates aldose reductase mRNA in rat renal inner medulla. (1996) (8)
- Transformation of leukotriene D4 catalyzed by lysosomal cathepsin H of rat liver. (1983) (8)
- Reversible conversion of lysine monooxygenase to an oxidase by modification of sulfhydryl groups. (1973) (8)
- Syntheses and anti-inflammatory activities of O-acyloximes. II. (1996) (8)
- Involvement of prostaglandin E2 in ornithine decarboxylase induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis. (1992) (8)
- Genomic cloning and characterization of the mouse POZ/zinc-finger protein ZF5. (1998) (8)
- Prednisolone-3,20-bisguanylhydrazone: the mode of interaction with rat brain sodium and potassium-activated adenosine triphosphatase. (1978) (8)
- Brain and peripheral anandamide amidohydrolase and its inhibition by synthetic arachidonate analogues. (1997) (8)
- Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. (1995) (8)
- Immunoaffinity Purification of Prostaglandin E2 and Leukotriene C4 Prior to Radioimmunoassay: Application to Human Synovial Fluid (1993) (8)
- High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol. (2001) (8)
- Influence of glycerol on the activity and tetramer-dimer state of lactate dehydrogenase isozymes. (1988) (8)
- Characterization of endogenous substrates for novel-type protein kinase C as well as conventional-type protein kinase C in primary cultured mouse epidermal cells. (1992) (8)
- Possible involvement of phospholipase A2 activation and lipoxygenase product(s) in the mechanism of insulin secretion. (1983) (8)
- Heterologous protein production in Acremonium chrysogenum: expression of bacterial cephalosporin C acylase and human thrombomodulin genes. (1997) (7)
- Obesity Induced in Mice Injected Intracerebrally with 4-Nitroquinoline 1-Oxide or 4-Hydroxyaminoquinoline 1-Oxide 1 (1970) (7)
- Sex dependence of the components and structure of urinary calculi induced by biphenyl administration in rats. (2000) (7)
- Effects of dilazep on fibrinolytic system in animals. I. Enhancement of fibrinolytic activity by administered dilazep in ex vivo experiment. (1982) (7)
- Biphasic kinetics of imipramine N-oxidation in rat brain microsomes. (1999) (7)
- Differential effects of diacylglycerols and 12-O-tetradecanoylphorbol-13-acetate on protein phosphorylation and cell proliferation of tumor promoter-dependent leukemia cell line A65T. (1988) (7)
- Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs. (1997) (7)
- Prevention of catecholamine release from adrenal chromaffin cells by phospholipase A2- and lipoxygenase-inhibitors. (1983) (7)
- Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis. (1996) (7)
- Insulinotropic effect of the tumor promoter teleocidin in isolated pancreatic islets. (1983) (7)
- Role of nitric oxide production in carbachol-induced negative chronotropy in cultured rat ventricular myocytes. (1999) (6)
- Studies on monooxygenases. IV. Anaerobic formation of an -keto acid by L-lysine monooxygenase. (1972) (6)
- Studies on ergot alkaloids and related compounds. 13. Syntheses and stereochemistries of 4-methyl-1,2,3-4,4a,5,6,10b-octahydrobenzo[f]quinoline-2-carboxylic acids. (1966) (6)
- Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models. (1997) (6)
- Studies on the reaction specificity of the flavoprotein lysine monooxygenase with modified substrates. (1976) (6)
- Prednisolone-3,20-bisguanylhydrazone: binding in vitro to sodium-and-potassium-activated adenosine triphosphatase of guinea pig heart ventricular muscle. (1978) (6)
- Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment. (1997) (6)
- Hormonal control of mRNA expression of immunoglobulin binding factor in uterine cervix. (2000) (6)
- Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models. (1991) (5)
- A simple preparation method for apoaspartate aminotransferase from Escherichia coli B, and its application for the assay of pyridoxal and pyridoxamine 5'-phosphate. (1985) (5)
- Purification and characterization of two forms of cytochrome P-450 from rat kidney cortex microsomes. (1986) (5)
- Cardiovascular effects of a new inotropic agent, denopamine (TA-064); with reference to it's effects on cardiac hemodynamics and metabolism. (1986) (5)
- (9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesis. (2000) (5)
- Modulation of pump function by mutations in the first transmembrane region of Na(+)-K(+)-ATPase alpha 1-subunit. (1996) (5)
- Separation of two forms of cytochrome P-450 with aryl hydrocarbon hydroxylase activity from intestinal mucosa microsomes of rabbits treated with 3-methylcholanthrene. (1983) (5)
- NaCl and/or urea infusion fails to increase renal inner medullary myo-inositol in protein-deprived rats. (1996) (5)
- Studies on ergot alkaloids and related compounds. XIV. Synthesis of N-alkyl-4-methyl-2,3,4,4a,5,6-hexahydrobenzo[f]quinoline-2-carboxamides and stereochemistry of diethyl 4-methyl-1-oxo-1,2,3,4,4a,5,6,10b-octahydro-benzo[f]quinoline-2,2-dicarboxylate. (1967) (4)
- General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics. (1991) (4)
- H4-isozyme of lactate dehydrogenase in the solution of sodium chloride--3. The enzymatic activity and the pyruvate inhibition. (1983) (4)
- Immunoaffinity purification of arachidonate 5-lipoxygenase from porcine leukocytes. (1990) (4)
- Dual regulation of alkaline phosphatase activity by calcitonin in porcine kidney cells. (1997) (4)
- Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis. (1992) (4)
- Formation of hydroxynorspermidine from exogenously added 1,3-diaminopropan-2-ol in Vibrio species. (1989) (4)
- Binding of human tissue plasminogen activator (t-PA) to blood clots and clot-lytic activity of clot-bound t-PA. (1990) (4)
- Structure-activity relationship study of TXA2 receptor antagonists. 4-[2-(4-substituted phenylsulfonylamino)ethylthio]phenoxyacetic acids and related compounds. (1995) (4)
- A dehydrogenase reaction catalyzed by lysine monooxygenase, a flavooxygenase. (1976) (4)
- Effect of polyanions and polycations on adenosine 3',5'-monophosphate-binding and protein kinase activity. (1975) (4)
- Inhibitory effect of TMK688 on skin tumor initiation caused by 7,12-dimethylbenz[a]anthracene in relation to inhibition of aryl hydrocarbon hydroxylase activity and Cyp1a1 mRNA induction. (1996) (4)
- Dimethylthiourea reduces pancreatic islet-cell damage in DBA/1 sucking mice with reovirus type-2 infection. (1997) (4)
- Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan. (1998) (4)
- Fibrinolytic effect of tissue plasminogen activator on cerebral embolism in stroke-prone spontaneously hypertensive rats. (1991) (4)
- Characterization of arachidonate 12-lipoxygenase found in the liver of mongrel dog and its immunohistochemical localization in neutrophils. (1995) (3)
- [Inhibitory effects of saiboku-to and compornent herbs on the production of peptide leukotrienes (LTs) and LTB4]. (1996) (3)
- Involvement of prostaglandin E2 in the tumor promoter phorbol ester-caused increase in epidermal cholesterol sulfotransferase activity. (1991) (3)
- Application of an alpha-sidechain length-specific monoclonal antibody to immunoaffinity purification and enzyme immunoassay of 2,3-dinor-6-keto-prostaglandin F1 alpha from human urine. (1994) (3)
- Anti-inflammatory action of orally active 5-lipoxygenase inhibitor TMK688. (1994) (3)
- Synergistic stimulation of prostaglandin E2 release by epidermal growth factor and a tumor promoter anthralin from primary cultures of mouse epidermal cells. (1991) (3)
- Comparison of some biochemical properties of epidermis in tumor promotion-susceptible and -resistant strains of mice. (1988) (3)
- Enzymological and molecular biological studies on anandamide amidohydrolase. (1999) (3)
- Intracellular predominance of the pyridoxal 5'-phosphate form of aspartate aminotransferase in Escherichia coli B and reversible transformation of this form by extracellular substances. (1989) (3)
- Localization of tissue plasminogen activator on experimental thrombi in rats. (1990) (3)
- Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis. (1988) (3)
- Activation of phorbol ester responsive form of protein kinase C zeta in association with Ca(2+)-induced differentiation of primary cultured mouse epidermal cells. (1997) (2)
- Effects of various triamines on cell-free polypeptide synthesis of Escherichia coli and on growth of its polyamine auxotrophs. (1990) (2)
- Anthralin, a non-TPA type tumor promoter, synergistically enhances phorbol ester-caused prostaglandin E2 release from primary cultured mouse epidermal cells. (1992) (2)
- Inhibition of calcium uptake and catecholamine release by 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8) in cultured bovine adrenal chromaffin cells. (1984) (2)
- Enzyme immunoassay of prostanoids in human blood and urine. (1985) (2)
- Induction of protein kinase Czeta-related protein kinase by growth suppression in carcinogen-initiated epidermal cell-line WYF31 cells. (2000) (2)
- Immunocytochemical localization of prostaglandin endoperoxide synthase in the bovine intestine (1993) (2)
- Role of phosphodiesterase 4 isoenzyme in alkaline phosphatase activation by calcitonin in porcine kidney LLC-PK1 cells. (1998) (2)
- Tissue distribution and subcellular localization of platelet-type arachidonate 12-lipoxygenase. (1997) (2)
- Cardiovascular system related peptides and hypothalamic neurons. (1995) (2)
- The induction of ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate in isolated epidermal cells is inhibited by lipoxygenase inhibitors but not by cyclooxygenase inhibitors. (1987) (2)
- H4-isozyme of lactate dehydrogenase in a solution of sodium C chloride--6. The effect of oxalate and oxamate on the molecular weight. (1983) (2)
- Enzyme immunoassay of PGF2 alpha. (1982) (2)
- Importance of sialic acid in recombinant thrombomodulin in terms of pharmacokinetics and separation of desialyzed glycoprotein. (1998) (2)
- Effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemic preconditioning in rabbits. (2002) (2)
- Phenotypic expression of carcinogen-initiated epidermal cells to tumor cells by 12-O-tetradecanoylphorbol-13-acetate in a manner dependent on 3T3 fibroblast-derived humoral factor(s). (1992) (1)
- Postmenopause-like bone loss by mammary carcinoma Walker256/S which secretes luteinizing hormone-releasing hormone. (1999) (1)
- KP-10, a novel protein kinase C substrate in intact mouse epidermal cells, is phosphorylated by novel protein kinase C eta and/or zeta. (1994) (1)
- Gene of rat Ca2+/calmodulin-dependent protein kinase II alpha isoform -- its cloning and whole structure. (1996) (1)
- General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on central nervous and sensory systems and other functions. (1991) (1)
- Production of prostaglandin E2 rather than E1 in experimental ocular inflammation of rabbit. (1989) (1)
- d-3-Dimethylamino-1,1-diphenylbutyl ethyl sulfone as a long-acting antitussive. (1958) (1)
- Effects of islet-activating protein on the catecholamine release, Ca2+ mobilization and inositol trisphosphate formation in cultured adrenal chromaffin cells. (1988) (1)
- Molecular and catalytic properties of mammalian lipoxygenases compared with soybean lipoxygenase-1. (1997) (1)
- An enzymatic method for the synthesis of [14C]pyridoxal 5'-phosphate from [14C]pyridoxine. (1986) (0)
- Enzyme immunoassay of 6-ketoprostaglandin F1 alpha in a solid phase. (1985) (0)
- [Stability of allantoin and identification of its degradation compounds]. (1993) (0)
- The rapid achievement of steady drug concentration in plasma (1978) (0)
- Distribution of aspartate aminotransferase activity in yeasts, and purification and characterization of mitochondrial and cytosolic isoenzymes from Rhodotorula minuta [corrected]. (1990) (0)
- [Reactivity of the vascular smooth muscle in stroke-prone spontaneously hypertensive rats]. (1978) (0)
- Platelet-type arachidonate 12-lipoxygenase. (1996) (0)
- Enzyme immunoassay of prostaglandin F2alpha. (1981) (0)
- [Enzyme immunoassay of prostaglandins]. (1987) (0)
- Inhibitory regulation of serum factor(s)-caused ornithine decarboxylase induction by the protein kinase C system in A431 human epidermoid carcinoma cells. (1991) (0)
- Gas chromatography-mass spectrometry of some prostanoids with new derivatizing agents. Application to the analysis of 13,14-dihydro-15-ketoprostaglandin F2 alpha. (1987) (0)
- single-channel conductance of the human L-type cardiac Ca2+ channel Single amino acid substitutions within the ion permeation pathway alter (2011) (0)
- Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of myocardial ischaemia. (1989) (0)
- Parathyroid hormone-related peptide-(1-34) [PTHrP-(1-34)] induces vasopressin release from the rat supraoptic nucleus in vitro through a novel receptor distinct from a type I or type II PTH/PTHrP receptor. (1997) (0)
- [Factors controlling tumor promotion induced by TPA]. (1986) (0)
- [Tumor promotion and arachidonic acid cascades]. (1993) (0)
- Interleukin 33 Is Induced by Tumor Necrosis Factor and Interferon in Keratinocytes and Contributes to Allergic Contact Dermatitis (2013) (0)
- H4-isozyme of lactate dehydrogenase in the solution of sodium chloride--II. The effect of ADP-ribose on the molecular weight. (1982) (0)
- Inhibition of leukotriene synthesis by terfenadine in vitro. (1998) (0)
- A lysosomal arylamidase is a member of a larger family of peptidases in lysosomes. (1994) (0)
- Development of enzyme immunoassay for serum 13,14-dihydro-15-ketoprostaglandin F2 alpha. (1986) (0)
- Protection against alloxan-induced diabetes in mice by stimulation of alpha 2-adrenergic receptors. (1983) (0)
- Differential sensitivities of transplacentally initiated newborn mouse epidermal cells to different tumor promoters. (1992) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shozo Yamamoto?
Shozo Yamamoto is affiliated with the following schools:
